Stay updated on Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial
Sign up to get notified when there's something new on the Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial page.

Latest updates to the Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial page
- ChecktodayChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. The visible study details appear unchanged in the current view.SummaryDifference0.0%

- Check43 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check50 days agoChange DetectedUpdated the Study Record Dates with a new last update posted on 2026-02-24 and a new last update submitted on 2026-02-20. Older dates (e.g., 2025-01-08, 2025-01-06) were removed.SummaryDifference0.3%

- Check65 days agoChange DetectedThe page shows a minor version update from v3.4.1 to v3.4.2 with no visible changes to trial information or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page update is limited to a revision notice from v3.4.0 to v3.4.1; there are no changes to study details or user workflows. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial page.